BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29388948)

  • 1. Clinical validity of phenotype-driven analysis software PhenoVar as a diagnostic aid for clinical geneticists in the interpretation of whole-exome sequencing data.
    Thuriot F; Buote C; Gravel E; Chénier S; Désilets V; Maranda B; Waters PJ; Jacques PE; Lévesque S
    Genet Med; 2018 Sep; 20(9):942-949. PubMed ID: 29388948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested.
    Basel-Salmon L; Orenstein N; Markus-Bustani K; Ruhrman-Shahar N; Kilim Y; Magal N; Hubshman MW; Bazak L
    Genet Med; 2019 Jun; 21(6):1443-1451. PubMed ID: 30377382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PhenoVar: a phenotype-driven approach in clinical genomics for the diagnosis of polymalformative syndromes.
    Trakadis YJ; Buote C; Therriault JF; Jacques PÉ; Larochelle H; Lévesque S
    BMC Med Genomics; 2014 May; 7():22. PubMed ID: 24884844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
    Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
    Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular findings among patients referred for clinical whole-exome sequencing.
    Yang Y; Muzny DM; Xia F; Niu Z; Person R; Ding Y; Ward P; Braxton A; Wang M; Buhay C; Veeraraghavan N; Hawes A; Chiang T; Leduc M; Beuten J; Zhang J; He W; Scull J; Willis A; Landsverk M; Craigen WJ; Bekheirnia MR; Stray-Pedersen A; Liu P; Wen S; Alcaraz W; Cui H; Walkiewicz M; Reid J; Bainbridge M; Patel A; Boerwinkle E; Beaudet AL; Lupski JR; Plon SE; Gibbs RA; Eng CM
    JAMA; 2014 Nov; 312(18):1870-9. PubMed ID: 25326635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.
    Rochtus A; Olson HE; Smith L; Keith LG; El Achkar C; Taylor A; Mahida S; Park M; Kelly M; Shain C; Rockowitz S; Rosen Sheidley B; Poduri A
    Epilepsia; 2020 Feb; 61(2):249-258. PubMed ID: 31957018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [UTILIZATION OF WHOLE EXOME SEQUENCING IN DIAGNOSTICS OF GENETIC DISEASE: RABIN MEDICAL CENTER'S EXPERIENCE].
    Cohen L; Orenstein N; Weisz-Hubshman M; Bazak L; Davidov B; Reinstein E; Tzur S; Behar D; Smirin-Yosef P; Salmon-Divon M; Gross A; Shohat M; Basel-Vanagaite L
    Harefuah; 2017 Apr; 156(4):212-216. PubMed ID: 28551919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates.
    Al-Shamsi A; Hertecant JL; Souid AK; Al-Jasmi FA
    Orphanet J Rare Dis; 2016 Jul; 11(1):94. PubMed ID: 27391121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.
    Landstrom AP; Fernandez E; Rosenfeld JA; Yang Y; Dailey-Schwartz AL; Miyake CY; Allen HD; Penny DJ; Kim JJ
    Heart Rhythm; 2018 Jul; 15(7):1042-1050. PubMed ID: 29501670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
    Yang Y; Muzny DM; Reid JG; Bainbridge MN; Willis A; Ward PA; Braxton A; Beuten J; Xia F; Niu Z; Hardison M; Person R; Bekheirnia MR; Leduc MS; Kirby A; Pham P; Scull J; Wang M; Ding Y; Plon SE; Lupski JR; Beaudet AL; Gibbs RA; Eng CM
    N Engl J Med; 2013 Oct; 369(16):1502-11. PubMed ID: 24088041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
    Seo GH; Kim T; Choi IH; Park JY; Lee J; Kim S; Won DG; Oh A; Lee Y; Choi J; Lee H; Kang HG; Cho HY; Cho MH; Kim YJ; Yoon YH; Eun BL; Desnick RJ; Keum C; Lee BH
    Clin Genet; 2020 Dec; 98(6):562-570. PubMed ID: 32901917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Improved Phenotype-Driven Tool for Rare Mendelian Variant Prioritization: Benchmarking Exomiser on Real Patient Whole-Exome Data.
    Cipriani V; Pontikos N; Arno G; Sergouniotis PI; Lenassi E; Thawong P; Danis D; Michaelides M; Webster AR; Moore AT; Robinson PN; Jacobsen JOB; Smedley D
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32340307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.